Keryx Biopharmaceuticals (KERX) Upgraded by BidaskClub to "Hold"

The biopharmaceutical company reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.18) by ($0.08). The Company has 121.68 million shares outstanding and 117.33 million shares were floated in market. The stock increased 1.65% or $1.56 during the last trading session, reaching $95.82. Gagnon Advisors Llc sold 75,356 shares as the company's stock rose 13.11% while stock markets declined. It is down 0.00% since April 28, 2017 and is. It has outperformed by 46.88% the S&P500.

KERX is reaching $4.78 during the last trading session, after decreased 1.65%.Currently Keryx Biopharmaceuticals, Inc.is downtrending after 32.44% change in last April 29, 2017.

The short ratio in the company's stock is documented at 17.51 and the short float is around of 18.38%. The institutional investor held 21,601 shares of the health care company at the end of 2017Q4, valued at $100.45 million, up from 9,603 at the end of the previous reported quarter. Currently, the stock is -4.91% from its 50-Day High and 26.28% from the 50-day low. About 377,256 shares traded.

Keryx Biopharmaceuticals (NASDAQ:KERX) last released its quarterly earnings data on Wednesday, February 7th.

Among 2 analysts covering Keryx Biopharmaceuticals (NASDAQ:KERX), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 40% are positive. Citigroup stated it has 0% of its portfolio in Keryx Biopharmaceuticals, Inc. Brean Capital downgraded the shares of KERX in report on Tuesday, August 2 to "Hold" rating. As per Thursday, February 8, the company rating was maintained by Morgan Stanley. The firm earned "Neutral" rating on Wednesday, June 1 by BTIG Research. The stock has "Buy" rating by TH Capital on Monday, August 10. The firm has "Buy" rating by Maxim Group given on Thursday, August 6. Morgan Stanley dropped their price objective on Keryx Biopharmaceuticals from $7.00 to $6.00 and set an "equal weight" rating on the stock in a research note on Thursday, February 8th. The rating was maintained by Maxim Group with "Buy" on Thursday, July 27.

Since October 30, 2017, it had 0 insider buys, and 17 insider sales for $314,623 activity.


In other news, insider Greg Madison sold 15,318 shares of the business's stock in a transaction that occurred on Thursday, February 15th. Raymond James Advisors owns 16,585 shares or 0% of their USA portfolio. Insiders have sold a total of 34,129 shares of company stock valued at $163,957 over the last three months. (NASDAQ:KERX) in a research report sent to investors on Tuesday.

Bnp Paribas Arbitrage Sa, which manages about $58089.88 billion US Long portfolio, decreased its stake in Ugi Corp (NYSE:UGI) by 263,348 shares to 80,381 shares, valued at $3.77 billion in 2017Q4, according to the filing. Finally, Clearbridge LLC grew its holdings in Keryx Biopharmaceuticals by 67.7% in the 4th quarter.

Investors sentiment decreased to 1.02 in Q4 2017. It has change of 0.48, from 2017Q3's 1.5.

BlackRock Inc. boosted its holdings in shares of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). National Bank & Trust Of Mellon has 943,863 shs. 2,026 Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). 20,994 are owned by Metropolitan Life Ins Communications New York. Geode Mgmt Limited Liability Corp holds 0% or 912,179 shares. Deltec Asset Llc invested in 0.02% or 20,000 shs. (NASDAQ:KERX) on Monday, January 29. (NASDAQ:KERX) for 23,650 shares. Principal Grp holds 0% of its portfolio in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) PTs and latest ratings.

State Of Wisconsin Investment Board holds 61,000 shares or 0% of its portfolio. Harvey Mngmt has 0.06% invested in Keryx Biopharmaceuticals, Inc. Janney Montgomery Scott Ltd Co holds 0% of its capital in Keryx Biopharmaceuticals, Inc. Morgan Stanley upgraded Keryx Biopharmaceuticals, Inc. "Consequently, shares of the company underperformed the industry". Sunbelt Secs Inc reported 3,734 shares. 134 funds opened positions while 676 raised stakes. Hl Ltd Com accumulated 0% or 15,000 shs. Fmr Ltd stated it has 1.69M shares or 0% of all its holdings. Muhlenkamp & accumulated 228,862 shares. Rhumbline Advisers reported 84,306 shares. Walter And Keenan Financial Consulting Commerce Mi Adv reported 94,555 shares.

Cadinha & Co Llc, which manages about $952.64 million and $723.95 million US Long portfolio, decreased its stake in Ishares Us Treas Bond Etf (GOVT) by 968,998 shares to 554,652 shares, valued at $13.91 million in 2017Q4, according to the filing. Signature And Inv Advsrs Ltd Liability Company reported 4,019 shares.

Related:

Comments

Latest news

Become an escape room Game Master 101
A good GM is sociable and easy going, stress resistant, attentive to details, responsible and flexible. GM knows the rooms perfectly well, can help the team with the clues at any time by giving hints.

Earnings Analysis Of Exxon Mobil Corporation (XOM)
Harkey increased its stake in Dolby Laboratories Inc (DLB) by 295.17% based on its latest 2017Q4 regulatory filing with the SEC. Numeric Investors Limited Liability Company has invested 0.02% in Exelixis, Inc. (NASDAQ:VRSK) for 15,451 shares.

Russell Brand cancels tour following mum's serious vehicle accident
Barbara Brand, 71, was taken to hospital last week after she was badly injured in a hit-and-run auto crash. The comic had ten more Re:Birth dates scheduled for next month, including the Manchester Apollo tomorrow.

Some caravan backers climb border wall at rally
The migrants marched from Friendship Park in Tijuana, Mexico to the San Ysidro port of entry on Sunday. Hundreds of Central Americans have travelled to the USA border wall in Mexico to claim asylum.

Online Sports Betting Market Growth
Benefits With the market high, sports betting is an activity that receives a high level of support from online betting companies. More betters are opting to forego the long lines at the cashier's counter and the unavailability of their favorite machines.

Other news